Scientists weaponize common cold virus to attack cancer in groundbreaking trial
Disease control
Recruiting now
This is the first time a new experimental drug called ATTR-01 is being tested in people. The drug is made from a modified common cold virus designed to specifically infect cancer cells and deliver an immune-boosting therapy to help the body fight the tumor. The trial will first f…
Phase: PHASE1, PHASE2 • Sponsor: Accession Therapeutics Limited • Aim: Disease control
Last updated Apr 02, 2026 04:26 UTC